AXA raises targets, expands Asia and AI while favoring organic growth
H1 profit up, full-year guidance at top end AXA's first-half net income rose 6% to €4.17bn on premium growth, and management now expects full-year earnings growth at the top of its 6-8% target. That signals the core business is performing well, supporting the shares.
Strong results and raised guidance are the main fundamental support for the stock.
New 2027-29 plan: organic growth and shareholder returns At its September 15 investor day, AXA raised three-year profitability and growth targets and said it will focus on organic growth and returning cash to shareholders rather than big acquisitions. That reduces deal risk and appeals to investors.
The new strategic plan sets the company's direction and capital priorities for the next three years.
Asia expansion: Hong Kong lease, new medical product AXA signed a 10-year lease for a new Hong Kong distribution and wealth hub and launched a cross-border medical plan for the Greater Bay Area. Both deepen its presence in a fast-growing region and add future premium income.
These moves expand AXA's distribution and product reach in Asia, a key growth market.
AI push: BytePlus partnership and regulatory sandbox AXA Hong Kong signed an AI deal with BytePlus and joined Hong Kong's GenA.I. Sandbox++ to test AI governance. Using AI in underwriting, claims and customer service could cut costs and improve service over time.
AI adoption is a long-term efficiency and competitiveness driver for the insurer.